Prothena Corporation plc(PRTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRTA Prothena Corporation plc

未开盘 07-28 16:00:00 EDT

6.87

+0.19

+2.84%

盘后6.74

-0.13-1.89%

19:31 EDT

最高6.89	最低6.63	成交量80.48万
今开6.71	昨收6.68	日振幅3.96%
总市值3.70亿	流通市值2.79亿	总股本5,383万
成交额546.88万	换手率1.98%	流通股本4,066万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRTA","market":"US","secType":"STK","nameCN":"Prothena Corporation plc","latestPrice":6.87,"timestamp":1753732800000,"preClose":6.68,"halted":0,"volume":804766,"hourTrading":{"tag":"盘后","latestPrice":6.74,"preClose":6.87,"latestTime":"19:31 EDT","volume":26690,"amount":183323.395,"timestamp":1753745490473},"delay":0,"floatShares":40657758,"shares":53826982,"eps":-2.049544,"marketStatus":"未开盘","change":0.19,"latestTime":"07-28 16:00:00 EDT","open":6.71,"high":6.89,"low":6.6257,"amount":5468811.49598,"amplitude":0.039566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.049544,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753776000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1355806800000,"exchange":"NASDAQ","adjPreClose":6.68,"preHourTrading":{"tag":"盘前","latestPrice":6.69,"preClose":6.68,"latestTime":"09:25 EDT","volume":1140,"amount":7540.899702000001,"timestamp":1753709100054},"postHourTrading":{"tag":"盘后","latestPrice":6.74,"preClose":6.87,"latestTime":"19:31 EDT","volume":26690,"amount":183323.395,"timestamp":1753745490473},"volumeRatio":1.054504,"impliedVol":1.2192,"impliedVolPercentile":0.7108},"requestUrl":"/m/hq/s/PRTA","defaultTab":"news","newsList":[{"id":"2550524313","title":"Prothena Corporation Plc盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550524313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550524313?lang=zh_cn&edition=full","pubTime":"2025-07-09 00:14","pubTimestamp":1751991264,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日00时14分，Prothena Corporation Plc股票出现波动，股价大幅拉升5.25%。截至发稿，该股报6.62美元/股，成交量39.136万股，换手率0.73%，振幅4.85%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为1.20%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709001424a43e6cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709001424a43e6cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRTA","BK4139","IE00B19Z6F94.USD","BK4572","IE0034390439.USD","AL","BK4104","LU1169590202.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2548866058","title":"Prothena Corporation Plc盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548866058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548866058?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:11","pubTimestamp":1751386293,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时11分，Prothena Corporation Plc股票出现波动，股价大幅上涨5.11%。截至发稿，该股报6.38美元/股，成交量52.8701万股，换手率0.98%，振幅6.75%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为1.19%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070200113497961aa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070200113497961aa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z6F94.USD","BK4139","LU1169590202.USD","IE0034390439.USD","BK4104","PRTA","AL","LU1169589451.USD","BK4572"],"gpt_icon":0},{"id":"2546756472","title":"Prothena Corporation Plc盘中异动 快速拉升5.01%报6.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546756472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546756472?lang=zh_cn&edition=full","pubTime":"2025-06-27 03:25","pubTimestamp":1750965957,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日03时25分，Prothena Corporation Plc股票出现异动，股价大幅拉升5.01%。截至发稿，该股报6.29美元/股，成交量137.393万股，换手率2.55%，振幅7.51%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.54%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627032557952d0286&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627032557952d0286&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169590202.USD","BK4104","BK4572","BK4139","PRTA","LU1169589451.USD","IE0034390439.USD","AL","IE00B19Z6F94.USD"],"gpt_icon":0},{"id":"2545141701","title":"Prothena Corporation Plc盘中异动 早盘股价大涨5.33%报6.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545141701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545141701?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:40","pubTimestamp":1750686044,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时40分，Prothena Corporation Plc股票出现波动，股价急速上涨5.33%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.33%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。消息层面，截至21时40分，《坎托·菲茨杰拉德维持Prothena持有评级》资讯为影响Prothena Corporation Plc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506232140459528185c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506232140459528185c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBO","BK4007","LU1169590202.USD","BK4572","LU1169589451.USD","BK4139","IE00B19Z6F94.USD","PRTA","IE0034390439.USD","AL","BK4104"],"gpt_icon":0},{"id":"2544117823","title":"Prothena Corporation Plc盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544117823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544117823?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:35","pubTimestamp":1750426524,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时35分，Prothena Corporation Plc股票出现异动，股价快速拉升5.22%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.33%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。消息层面，截至21时35分，《奥本海默控股维持Prothena持有评级》资讯为影响Prothena Corporation Plc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213525978809ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213525978809ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169590202.USD","BK4104","BK4572","BK4139","PRTA","LU1169589451.USD","IE0034390439.USD","AL","IE00B19Z6F94.USD"],"gpt_icon":0},{"id":"2544994570","title":"Prothena Corporation Plc盘中异动 股价大涨5.30%报5.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544994570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544994570?lang=zh_cn&edition=full","pubTime":"2025-06-18 00:55","pubTimestamp":1750179328,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日00时55分，Prothena Corporation Plc股票出现异动，股价急速拉升5.30%。截至发稿，该股报5.96美元/股，成交量164.353万股，换手率3.05%，振幅7.42%。Prothena Corporation Plc股票所在的生物技术行业中，整体跌幅为0.89%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。消息层面，截至00时55分，《奥本海默控股维持Prothena持有评级》资讯为影响Prothena Corporation Plc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618005528a4aec274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618005528a4aec274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z6F94.USD","BK4139","LU1169590202.USD","IE0034390439.USD","BK4104","PRTA","AL","LU1169589451.USD","BK4572"],"gpt_icon":0},{"id":"2543083776","title":"Prothena Corporation Plc盘中异动 早盘急速上涨9.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543083776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543083776?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:31","pubTimestamp":1750080683,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时31分，Prothena Corporation Plc股票出现异动，股价急速拉升9.06%。截至发稿，该股报5.54美元/股，成交量26.2785万股，换手率0.49%，振幅2.91%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.02%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213125a70c33d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213125a70c33d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z6F94.USD","LU1169590202.USD","BK4104","BK4139","AL","PRTA","IE0034390439.USD","LU1169589451.USD","BK4572"],"gpt_icon":0},{"id":"2542380209","title":"Prothena Corporation Plc盘中异动 大幅下挫5.54%报5.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542380209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542380209?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:37","pubTimestamp":1749476270,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时37分，Prothena Corporation Plc股票出现波动，股价大幅跳水5.54%。截至发稿，该股报5.11美元/股，成交量57.6021万股，换手率1.07%，振幅6.28%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.68%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092137519514d5e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092137519514d5e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","PRTA","IE00B19Z6F94.USD","BK4104","IE0034390439.USD","BK4572","BK4139","LU1169590202.USD","AL"],"gpt_icon":0},{"id":"2539266422","title":"Prothena Corporation Plc盘中异动 早盘快速上涨5.00%报4.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539266422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539266422?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:46","pubTimestamp":1748526390,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时46分，Prothena Corporation Plc股票出现异动，股价急速上涨5.00%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.44%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。该信息摘要如下：B of A Securities：下调Prothena Corp评级，由中性调整至低于大市评级, 目标价由22.00美元调整至4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292146309769e54c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292146309769e54c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4572","ALZN","IE00B19Z6F94.USD","BK4539","PRTA","AL","BK4104","IE0034390439.USD","BK4139"],"gpt_icon":0},{"id":"2539485405","title":"B of A Securities：下调Prothena Corp(PRTA.US)评级，由中性调整至低于大市评级, 目标价由22.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539485405","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539485405?lang=zh_cn&edition=full","pubTime":"2025-05-29 02:32","pubTimestamp":1748457145,"startTime":"0","endTime":"0","summary":"B of A Securities：下调Prothena Corp(PRTA.US)评级，由中性调整至低于大市评级, 目标价由22.00美元调整至4.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/29023250729096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PRTA"],"gpt_icon":0},{"id":"2538349590","title":"奥本海默：下调Prothena Corp(PRTA.US)评级，由优于大市调整至Perform评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538349590","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538349590?lang=zh_cn&edition=full","pubTime":"2025-05-28 00:51","pubTimestamp":1748364716,"startTime":"0","endTime":"0","summary":"奥本海默：下调Prothena Corp(PRTA.US)评级，由优于大市调整至Perform评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/28005150697651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PRTA"],"gpt_icon":0},{"id":"2538046485","title":"Prothena Corporation Plc盘中异动 早盘大幅跳水29.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538046485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538046485?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:31","pubTimestamp":1748352687,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时31分，Prothena Corporation Plc股票出现异动，股价大幅下挫29.41%。截至发稿，该股报4.65美元/股，成交量98.4354万股，换手率1.83%，振幅2.33%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.65%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213127a48e738f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213127a48e738f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0034390439.USD","IE00B19Z6F94.USD","BK4139","AL","BK4104","PRTA","BK4572"],"gpt_icon":0},{"id":"2536582145","title":"Prothena Corporation Plc2025财年第一财季实现净利润-60.20百万美元，同比增加16.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582145","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536582145?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497651,"startTime":"0","endTime":"0","summary":"5月18日，Prothena Corporation Plc公布财报，公告显示公司2025财年第一财季净利润为-60.20百万美元，同比增加16.67%；其中营业收入为2.83百万美元，同比增加5560.00%，每股基本收益为-1.12美元。从资产负债表来看，Prothena Corporation Plc总负债57.66百万美元，其中短期债务2.63百万美元，资产负债比为0.09，流动比率为0.09。机构评级：截至2025年5月18日，当前有8家机构对Prothena Corporation Plc目标价做出预测，其中目标均价为49.00美元，其中最低目标价为18.00美元，最高目标价为110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000446a4821eb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000446a4821eb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRTA"],"gpt_icon":0},{"id":"2535314373","title":"Prothena Corporation Plc盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535314373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535314373?lang=zh_cn&edition=full","pubTime":"2025-05-16 22:48","pubTimestamp":1747406923,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日22时48分，Prothena Corporation Plc股票出现波动，股价快速上涨5.11%。截至发稿，该股报7.06美元/股，成交量17.6083万股，换手率0.33%，振幅6.08%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.42%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051622484494f91b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051622484494f91b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE00B19Z6F94.USD","AL","IE0034390439.USD","PRTA","BK4104","BK4572"],"gpt_icon":0},{"id":"2535382019","title":"Prothena Corporation Plc盘中异动 早盘急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535382019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535382019?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:49","pubTimestamp":1747320567,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时49分，Prothena Corporation Plc股票出现异动，股价大幅下跌5.01%。截至发稿，该股报6.54美元/股，成交量22.9635万股，换手率0.43%，振幅5.16%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.47%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224927975ad033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224927975ad033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRTA","BK4139","IE00B19Z6F94.USD","BK4572","IE0034390439.USD","AL","BK4104"],"gpt_icon":0},{"id":"2535074202","title":"Prothena Corporation Plc盘中异动 快速下跌5.01%报7.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535074202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535074202?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:25","pubTimestamp":1747232741,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时25分，Prothena Corporation Plc股票出现异动，股价急速下挫5.01%。截至发稿，该股报7.21美元/股，成交量23.045万股，换手率0.43%，振幅6.19%。Prothena Corporation Plc股票所在的生物技术行业中，整体跌幅为0.21%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514222542aa2c8e8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514222542aa2c8e8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z6F94.USD","BK4104","BK4139","AL","PRTA","IE0034390439.USD","BK4572"],"gpt_icon":0},{"id":"2534434658","title":"摩根大通证券公司：维持Prothena Corp(PRTA.US)评级，由优于大市调整至优于大市评级, 目标价由80.00美元调整至78.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534434658","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534434658?lang=zh_cn&edition=full","pubTime":"2025-05-09 23:25","pubTimestamp":1746804309,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Prothena Corp(PRTA.US)评级，由优于大市调整至优于大市评级, 目标价由80.00美元调整至78.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09232550280595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159848","PRTA","399975"],"gpt_icon":0},{"id":"2534876594","title":"Prothena Corporation Plc盘中异动 大幅拉升5.35%报7.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534876594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534876594?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:31","pubTimestamp":1746797507,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时31分，Prothena Corporation Plc股票出现异动，股价急速拉升5.35%。截至发稿，该股报7.48美元/股，成交量7.7423万股，换手率0.14%，振幅5.92%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.17%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213148a6d92c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213148a6d92c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z6F94.USD","BK4139","IE0034390439.USD","BK4104","PRTA","AL","BK4572"],"gpt_icon":0},{"id":"2532840222","title":"Prothena Corporation Plc盘中异动 早盘快速拉升6.65%报9.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532840222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532840222?lang=zh_cn&edition=full","pubTime":"2025-05-02 22:29","pubTimestamp":1746196176,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日22时29分，Prothena Corporation Plc股票出现异动，股价急速上涨6.65%。截至发稿，该股报9.30美元/股，成交量14.1309万股，换手率0.26%，振幅4.53%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为0.84%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502222936aa2c8223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502222936aa2c8223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0034390439.USD","BK4104","IBO","BK4572","BK4139","AL","PRTA","IE00B19Z6F94.USD","BK4007"],"gpt_icon":0},{"id":"2532006917","title":"Prothena Corporation Plc盘中异动 大幅下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532006917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532006917?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:35","pubTimestamp":1746034530,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日01时35分，Prothena Corporation Plc股票出现异动，股价快速跳水5.01%。截至发稿，该股报9.21美元/股，成交量27.7872万股，换手率0.52%，振幅3.77%。Prothena Corporation Plc股票所在的生物技术行业中，整体涨幅为1.32%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501013530974bcf90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501013530974bcf90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4572","BK4104","AL","PRTA","IE0034390439.USD","IE00B19Z6F94.USD","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prothena.com","stockEarnings":[{"period":"1week","weight":0.0922},{"period":"1month","weight":0.1299},{"period":"3month","weight":-0.291},{"period":"6month","weight":-0.5655},{"period":"1year","weight":-0.7188},{"period":"ytd","weight":-0.504}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prothena Corporation plc于2012年9月26日根据爱尔兰法律成立，并于2012年10月25日重新注册为爱尔兰公共有限公司。该公司是一家晚期临床生物技术公司，拥有蛋白质失调方面的专业知识和一系列研究疗法，有可能改变破坏性神经退行性疾病和罕见的周围淀粉样蛋白疾病的病程。该公司全资拥有的项目包括用于潜在治疗AL淀粉样变性的birtamimab，以及用于潜在治疗阿尔茨海默病的一系列项目，包括针对β-淀粉样蛋白（A β）的PRX012和新型A β-tau双联疫苗PRX123。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":-0.07393},{"month":2,"riseRate":0.615385,"avgChangeRate":0.098305},{"month":3,"riseRate":0.615385,"avgChangeRate":0.042907},{"month":4,"riseRate":0.384615,"avgChangeRate":-0.121904},{"month":5,"riseRate":0.538462,"avgChangeRate":0.016975},{"month":6,"riseRate":0.692308,"avgChangeRate":0.138177},{"month":7,"riseRate":0.769231,"avgChangeRate":0.11888},{"month":8,"riseRate":0.416667,"avgChangeRate":0.015008},{"month":9,"riseRate":0.416667,"avgChangeRate":0.042241},{"month":10,"riseRate":0.5,"avgChangeRate":-0.019107},{"month":11,"riseRate":0.583333,"avgChangeRate":0.07247},{"month":12,"riseRate":0.25,"avgChangeRate":-0.043888}],"exchange":"NASDAQ","name":"Prothena Corporation plc","nameEN":"Prothena Corp PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prothena Corporation plc(PRTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prothena Corporation plc(PRTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prothena Corporation plc,PRTA,Prothena Corporation plc股票,Prothena Corporation plc股票老虎,Prothena Corporation plc股票老虎国际,Prothena Corporation plc行情,Prothena Corporation plc股票行情,Prothena Corporation plc股价,Prothena Corporation plc股市,Prothena Corporation plc股票价格,Prothena Corporation plc股票交易,Prothena Corporation plc股票购买,Prothena Corporation plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prothena Corporation plc(PRTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prothena Corporation plc(PRTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}